Please wait a moment . . .

 
Jandhyala method

We @Medialis Ltd are pleased to share the first of a series of updates on the #medicalaffairs principles underlying our work, the four pillars of our medical #thirty22RWEstrategy in the #pharmaceuticalindustry, #rarediseases and #orphandrugs.

Pillar 1 of our strategy focuses on the application of #Neutraltheory to #constructmeasurement problems in #clinicaltrials and #clinicalstudies.

#Neutral theory allows us to quantify the accuracy of #construct measures used as #endpoints against an aspirational Neutral list, providing a measure not only of where we are in terms of construct measurement accuracy but also where we are striving to be.

Our current #corporatesocialresponsibility program is applying Neutral theory to disease-specific #QualityofLife and disease-severity scales, aiming to increase the accuracy of measurement in clinical studies and thus, patient classification.  Contact Medialis Ltd to find out how Neutral theory can enhance construct measurement for your patient group and new #medicine.

#medicalaffairs #pharmarceuticals #clinicalresearch

Leave a Reply

Your email address will not be published. Required fields are marked *